[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@gheraor9703 "@timothysykes $SPRO Phase X tebipenem results (oral carbapenem for cUTI) to be presented at #IDWeek with $GSK -potentially FDA submission next w. With 10-year exclusivity potential and no new safety issues this could be the most advanced oral option in its class. Quiet but interesting setup"
X Link @gheraor9703 2025-10-15T15:07Z XX followers, XX engagements

"@StocksToTrade @timothysykes $SPRO Phase X tebipenem results (oral carbapenem for cUTI) to be presented at #IDWeek with $GSK -potentially FDA submission next w. With 10-year exclusivity potential and no new safety issues this could be the most advanced oral option in its class. Quiet but interesting setup"
X Link @gheraor9703 2025-10-15T15:08Z XX followers, XX engagements

"@ej23ny $SPRO Phase X tebipenem results (oral carbapenem for cUTI) to be presented at #IDWeek with $GSK -potentially FDA submission. With 10-year exclusivity potential and no new safety issues this could be the most advanced oral option in its class. Quiet but interesting setup"
X Link @gheraor9703 2025-10-15T15:05Z XX followers, XX engagements

"@ej23ny Totally respect what $ABP is doing. But thats what makes $SPROs setup wild. $135M market cap with: -Completed Phase X (PIVOT-PO) -$GSK as development partner -Near-term FDA submission catalyst The market is still pricing it like a microcap pre-trial. Quiet accumulation phase"
X Link @gheraor9703 2025-10-15T15:58Z XX followers, XXX engagements